XOMAO vs OTF Comparison

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Blue Owl Technology Finance Corp is an externally managed business development company mainly formed to originate and make debt and equity investments in a broad range of established and high-growth technology-related companies based mainly in the United States. Its investment objective is to maximize total return by generating current income from debt investments and other income-producing securities, and capital appreciation from its equity and equity-linked investments. The company originates and invests in senior secured or unsecured loans; subordinated loans or mezzanine loans; and equity-related securities, including common equity, warrants, preferred stock, and similar forms of senior equity, which may or may not be convertible into a portfolio company's common equity.